Intravenous Immunoglobulin (IVIg)
Market
Intravenous Immunoglobulin (IVIg) Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
2031
Request Sample Report
Intravenous Immunoglobulin (IVIg) Market Size and Growth
The Intravenous Immunoglobulin (IVIg) market is experiencing significant growth, driven by increasing autoimmune disorders and neurological diseases. The global market size is projected to reach approximately $15 billion by 2026, with a compound annual growth rate (CAGR) of around 5%. Innovative therapies and expanding applications further enhance market opportunities.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Baxter
◍ CNBG
◍ Octapharma
◍ Grifols
◍ Hualan Bio
◍ CSL
◍ CBPO
◍ Kedrion
◍ Biotest
◍ Shanghai RAAS
◍ LFB Group
◍ BPL
◍ Sichuan Yuanda Shuyang
The Intravenous Immunoglobulin (IVIg) market features key players like Baxter, CNBG, and Grifols, each expanding through product innovation and broadening therapeutic applications. Companies such as CSL and Octapharma enhance market growth via strategic partnerships. Selected revenues include Baxter ($3.4 billion), Grifols ($2.9 billion), and CSL ($9.1 billion). Request Sample Report
Market Segmentation
By Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Request Sample Report
By Product
IVIg Liquid
IVIg Powder
Market Growth
Request Sample Report
$ X Billion USD
